Sarcoma  >>  izuralimab (XmAb23104)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
izuralimab (XmAb23104) / Xencor
NCT05879185: A Study of XmAb23104 in People With Sarcoma

Active, not recruiting
2
6
US
XmAb23104
Memorial Sloan Kettering Cancer Center, Xencor, Inc.
Sarcoma
04/25
04/25

Download Options